| Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687) |
|---|
| 01/26/2006 | CA2573138A1 Oxime derivative substituted hydroxyethylamine aspartyl protease inhibitors |
| 01/26/2006 | CA2572822A1 Dimeric piperidine derivatives |
| 01/26/2006 | CA2572775A1 Oxime derivative hydroxyethylamine aspartyl-protease inhibitors |
| 01/26/2006 | CA2570968A1 Gonadotropin releasing hormone receptor antagonists |
| 01/25/2006 | EP1619192A2 Aryl fused azapolycyclic compounds |
| 01/25/2006 | EP1618169A1 Electron transport agents for organic electronic devices |
| 01/25/2006 | EP1618098A2 1,2,4-oxadiazole benzoic acid compounds and their use for nonsense suppression and the treatment of disease |
| 01/25/2006 | EP1618093A2 Indazole derivatives as jnk inhibitors |
| 01/25/2006 | EP1618092A1 Aryl-substituted pyrazole-amide compounds useful as kinase inhibitors |
| 01/25/2006 | EP1617848A2 Anti-cancer phosphonate conjugates |
| 01/25/2006 | EP1617840A2 Pyrazole-amide compounds useful as kinase inhibitors |
| 01/25/2006 | EP1506179B1 Benzoxazine derivatives as 5-ht6 modulators and uses thereof |
| 01/25/2006 | EP1490363B1 Methods of preparation of the 2-(7-chloro-1,8-naphthyridine-2-yl)-3-(5-methyl-2-oxo-hexyl)-1-isoindolinone |
| 01/25/2006 | EP1235825B1 Novel benzoimidazole derivatives useful as antiproliferative agents |
| 01/25/2006 | EP0978392B1 Optical recording media |
| 01/25/2006 | EP0914158B2 Pharmaceutical combination containing a compound having angiotensin ii antagonistic activity and a compound which increases the insulin-sensitivity |
| 01/25/2006 | CN1726210A Novel compounds having selective inhibiting effect at GSK3 |
| 01/25/2006 | CN1726209A 3-substituted-4-pyrimidone derivatives |
| 01/25/2006 | CN1726207A Substituted 1-piperidin-4-yl-4-pyrrolidin-3-yl-piperazine derivatives and their use as neurokinin antagonists |
| 01/25/2006 | CN1726206A Triazole derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1 |
| 01/25/2006 | CN1726204A Enantiomers of thiophene hydroxamic acid derivatives and their use as hdac inhibitors |
| 01/25/2006 | CN1726197A 5-substituted-pyrazine or -pyridine glucokinase activators |
| 01/25/2006 | CN1726196A Pyrazine-based tubulin inhibitors |
| 01/25/2006 | CN1726194A Novel compounds |
| 01/25/2006 | CN1726042A Benzo[d]azepine derivatives for the treatment of neurological disorders |
| 01/25/2006 | CN1724519A Indole kind compound with insuline sensitizing activity and its preparation method and use |
| 01/25/2006 | CN1238354C Analog of nerve growth factor (2S, 4S)-2-(2'substituent)-4-(indole-3-methine)-5,5-disubstituent group-1, 3-f azole alkane compound, preparation method and application thereof |
| 01/25/2006 | CN1238347C Heterocyclic derivatives |
| 01/25/2006 | CN1238343C Pyrimidine derivatives and herbicides containing the same |
| 01/24/2006 | US6989398 Benzanilides as potassium channel openers |
| 01/24/2006 | US6989395 TNF inhibitors |
| 01/24/2006 | US6989392 2-Aminoquinolines as melanin concentrating hormone receptor antagonists |
| 01/24/2006 | US6989391 Lactam-containing compounds and derivatives thereof as factor Xa inhibitors |
| 01/24/2006 | US6989385 Pyrazole compounds useful as protein kinase inhibitors |
| 01/24/2006 | US6989381 Containing s cyclodextrin compound in a concentration sufficient to maintain the drug in solution at such a drug concentration. |
| 01/24/2006 | US6989379 Selective NPY (Y5) antagonists |
| 01/24/2006 | US6989139 Matrix metalloproteinase inhibitors |
| 01/24/2006 | CA2292984C Ccr5 modulators |
| 01/24/2006 | CA2166415C Acylated aminophenylsulfonylureas; preparation and use as herbicides and plant growth regulators |
| 01/24/2006 | CA2123093C Sulfonamide herbicides |
| 01/19/2006 | WO2006007532A2 2-substituted heteroaryl compounds |
| 01/19/2006 | WO2006006741A1 Fused benzamide compound and vanilloid receptor 1 (vr1) activity inhibitor |
| 01/19/2006 | WO2006006740A1 3-aminobenamide compound and vanilloid receptor 1 (vr1) activity inhibitor |
| 01/19/2006 | WO2006005918A1 2, 4,6-trisubstituted pyrimidines as phosphotidylinositol (pi) 3-kinase inhibitors and their use in the treatment of cancer |
| 01/19/2006 | WO2006005741A2 Piperdine derivatives as renin inhibitors |
| 01/19/2006 | WO2005097746A3 2-propene-1-ones as hsp 70 inducers |
| 01/19/2006 | WO2005095357A3 Pyrimidine derivatives and methods of treatment related to the use thereof |
| 01/19/2006 | WO2005075458A8 Pyrimidine derivatives as orexin receptors antagonists |
| 01/19/2006 | US20060014948 e.g 1-[3,5-bis(trifluoromethyl)benzoyl]-2-[3-[(2-methoxyethoxy)-methoxy]-4-methylbenzyl]-4-[2-[(3R)-3-methoxymethyl-morpholino]ethyl]piperazine; treating or preventing Tachykinin-mediated diseases in humans or animals |
| 01/19/2006 | US20060014836 e.g. 1-(Benzofuran-2-carbonyl-3-(3-phenoxy-phenyl)-thiourea;viricides; hepatitis virus |
| 01/19/2006 | US20060014816 such as: 3-{5-[3-(2-methoxyethoxy)-1-propynyl]-3-thienyl}-6-[(4-methyl-1-piperazinyl)methyl]-1,4-dihydroindeno[1,2-c]pyrazole; diseases resulting from inappropriate activation of the immune system (e.g., autoimmune disorders), allograft rejection, and graft vs. host disease |
| 01/19/2006 | US20060014796 Epothilone derivatives |
| 01/19/2006 | US20060014792 Heterocyclo inhibitors of potassium channel function |
| 01/19/2006 | US20060014761 Compounds, compositions and methods |
| 01/19/2006 | US20060014756 Benzimidazoles |
| 01/19/2006 | US20060014749 (R)-2-{4-[(1H-Indol-2-ylmethyl)-amino]-piperidin-1-yl}-1-(6-methoxyquinolin-4-yl)-ethanol; effective against both gramnegative and grampositive bacteria |
| 01/19/2006 | US20060014743 Methods of preventing bacterial infections with florfenicol-type antibiotics |
| 01/19/2006 | DE102004031323A1 Substituierte Pyridazincarboxamide und Derivate hiervon And derivatives thereof substituted Pyridazincarboxamide |
| 01/19/2006 | DE102004023332A1 Chinoxalin-2-on-derivate, diese enthaltende nutzpflanzenschützende Mittel und Verfahren zu ihrer Herstellung und deren Verwendung Quinoxalin-2-one derivatives, useful-plant-protecting compositions containing them and processes for their preparation and their use |
| 01/19/2006 | CA2571756A1 2, 4,6-trisubstituted pyrimidines as phosphotidylinositol (pi) 3-kinase inhibitors and their use in the treatment of cancer |
| 01/19/2006 | CA2571750A1 2, 4, 6-trisubstituted pyrimidines as phosphotidylinositol (pi) 3-kinase inhibitors and their use in the treatment of cancer |
| 01/19/2006 | CA2571748A1 2, 4, 6-trisubstituted pyrimidines as phosphotidylinositol (pi) 3-kinase inhibitors and their use in the treatment of cancer |
| 01/19/2006 | CA2571178A1 2-substituted heteroaryl compounds |
| 01/19/2006 | CA2570920A1 Piperidine derivatives as renin inhibitors |
| 01/18/2006 | EP1615917A1 N-aryl-2-oxazolidinone-5-carboxamides derivatives with antibacterial activity |
| 01/18/2006 | EP1615916A1 Antimicrobial 3.1.0 bicyclohexylphenyl-oxazolidinone derivatives and analogues |
| 01/18/2006 | EP1615915A1 Phenacyl 2-hydroxy-3-diaminoalkanes |
| 01/18/2006 | EP1615914A2 Cgrp receptor antagonists |
| 01/18/2006 | EP1615909A1 Piperazine derivatives and their use for the treatment of neurological and psychiatric diseases |
| 01/18/2006 | EP1615904A2 Substituted benzosulphonamide as potentiators of glutamate receptors |
| 01/18/2006 | EP1615899A1 Alpha-substituted carboxylic acids as ppar modulators |
| 01/18/2006 | EP1615898A1 2-aminopyrimidine derivatives and their medical use |
| 01/18/2006 | EP1615895A1 Biaryl substituted pyrazoles as sodium channel blockers |
| 01/18/2006 | EP1615886A1 [c]-fused bicyclic proline derivatives and their use for treating arthritic conditions |
| 01/18/2006 | EP1615885A1 B -fused bicyclic proline derivatives and their use for treating arthritic conditions |
| 01/18/2006 | EP1615878A2 Compounds, compositions and methods |
| 01/18/2006 | EP1615699A2 Benzoxazinyl-amidocyclopentyl-heterocyclic modulators of chemokine receptors |
| 01/18/2006 | EP1615633A2 Chemokine receptor binding heterocyclic compounds with enhanced efficacy |
| 01/18/2006 | EP1435951B1 Phenyl substituted 5-membered nitrogen containing heterocycles for the tretment of obesity |
| 01/18/2006 | EP1417204B1 Ortho-heterocyclic substituted aryl amides for controlling invertebrate pests |
| 01/18/2006 | EP1392309A4 Substituted pyrazinones, pyridines and pyrimidines as corticotropin releasing factor ligands |
| 01/18/2006 | EP1381601B1 Clathrate of azithromycin hydrate with 1,2-propyleneglycol, method for the manufacture thereof and pharmaceutical composition comprising same |
| 01/18/2006 | EP1194410B1 Benzimidazole derivatives and pharmaceutical compositions comprising these compounds |
| 01/18/2006 | CN1723209A Indol derivatives and their use as 5-HT ligands |
| 01/18/2006 | CN1723205A Substituted benzoxazinones and uses thereof |
| 01/18/2006 | CN1723204A Benzoxazole derivatives and their use as adenosine receptor ligands |
| 01/18/2006 | CN1723196A Fluoropyrrolidines as dipeptidyl peptidase inhibitors |
| 01/18/2006 | CN1723023A morpholine derivatives for use as dopamine agonists in the treatment of I.A. sexual dysfunction |
| 01/18/2006 | CN1721411A Benzimidazole derivatives as modulators IgE |
| 01/18/2006 | CN1237063C Fluorescent brightening agent and synthesis method of its mixture |
| 01/18/2006 | CN1237061C Chemokine receptor binding heterocyclic compounds |
| 01/18/2006 | CN1237055C 三唑衍生物 Triazole derivatives |
| 01/18/2006 | CN1237052C Ortho-substituted nitrogen-containing bisaryl compounds used as potassium channel inhibitors |
| 01/18/2006 | CN1237051C Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation |
| 01/18/2006 | CN1236767C Vitronectin receptor antagonists |
| 01/17/2006 | US6987189 an aryl substituted (pyridin-2-ylmethylsulfanyl) alkyl amine; antibiotic |
| 01/17/2006 | US6987122 Antitumor agents; solid tumors of rectum, lungs |
| 01/17/2006 | US6987114 Antiviral pyrimidinedione derivatives and process for the preparation thereof |
| 01/17/2006 | US6987104 Peptidyl deformylase inhibitors used for inhibiting bacteria or preventing bacterial contamination of a cell culture medium |
| 01/17/2006 | CA2229438C Mercaptoalkylpeptidyl compounds having an imidazole substituent and their use as inhibitors of matrix metalloproteinases (mmp) and/or tumour necrosis factor (tnf) |